Top Biotechnology & Medical Research stocks in North America

Researchers and developers of biotechnology based drugs and therapies as well as medical devices and procedures that are at an early (non-commercial) stage.

Name
Market Cap
Price to Earnings
TTM
Dividend Yield
% TTM
us flag iconSGENSeagen$43.15bnn/an/a
us flag iconINSMInsmed$35.04bnn/an/a
us flag iconIQVIqvia Holdings$34.77bn27.96n/a
us flag iconBNTXBioNTech SE$25.28bnn/an/a
us flag iconSMMTSummit Therapeutics$15.59bnn/an/a
us flag iconTEMTempus AI$15.25bnn/an/a
us flag iconMEDPMedpace Holdings$14.84bn39.27n/a
us flag iconICLRIcon$14.39bn16.62n/a
us flag iconASNDAscendis Pharma A/S$12.87bnn/an/a
us flag iconKRTXKaruna Therapeutics$12.58bnn/an/a
us flag iconIONSIonis Pharmaceuticals$11.65bnn/an/a
us flag iconEXASExact Sciences$11.59bnn/an/a
us flag iconEXELExelixis$10.57bn17.67n/a
us flag iconQGENQiagen NV$10.47bn24.38n/a
us flag iconRVMDRevolution Medicines$10.11bnn/an/a
us flag iconMDGLMadrigal Pharmaceuticals$9.78bnn/an/a
us flag iconTECHBIO-TECHNE$9.63bn50.380.52%
us flag iconRXDXPrometheus Biosciences$9.56bnn/an/a
us flag iconCRLCharles River Laboratories International$8.79bn55.27n/a
us flag iconIMGNImmunoGen$8.72bnn/an/a